secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001493152-25-018877
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Vuong Trieu presented at LD Micro conference on Oct 21; specifics not disclosed in filing
--------------------------------------------------------------------------------

- CEO Vuong Trieu presented a corporate presentation at LD Micro in San Diego on October 21, 2025.
- Exhibit 99.1 containing the presentation is attached but its content was not reproduced in this filing.
- No financial results, clinical updates, or guidance changes were provided in the 8-K text.
- This is a procedural 8.01 announcement of an investor presentation; no material operational detail.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315225018877/0001493152-25-018877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315225018877/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer